Safety and adherence to self-administered intravaginal 5-fluorouracil cream following cervical intraepithelial neoplasia (CIN) 2/3 treatment among HIV-positive women in Kenya: A phase 1 clinical trial
Chemtai Mungo, Jackton Omoto, Cirilus Ogollah, Antony Owaya, Mercy Rop, Gershon Rota, Elizabeth A Bukusi, Jennifer Tang, Lisa Rahangdale
doi: https://doi.org/10.1101/2024.06.06.24308548
Chemtai Mungo
1Department of Obstetrics and Gynecology, University of North Carolina-Chapel Hill, Chapel Hill, U.S.A
2Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill, Chapel Hill, U.SA
3Center for AIDS Research, University of North Carolina-Chapel Hill, Chapel Hill, U.SA
Jackton Omoto
4Department of Obstetrics and Gynecology, Maseno University School of Medicine, Maseno, Kenya
Cirilus Ogollah
5Center for Microbiology Research, Kenya Medical Research Institute, Kisumu, Kenya
Antony Owaya
5Center for Microbiology Research, Kenya Medical Research Institute, Kisumu, Kenya
Mercy Rop
5Center for Microbiology Research, Kenya Medical Research Institute, Kisumu, Kenya
Gershon Rota
5Center for Microbiology Research, Kenya Medical Research Institute, Kisumu, Kenya
Elizabeth A Bukusi
5Center for Microbiology Research, Kenya Medical Research Institute, Kisumu, Kenya
Jennifer Tang
1Department of Obstetrics and Gynecology, University of North Carolina-Chapel Hill, Chapel Hill, U.S.A
2Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill, Chapel Hill, U.SA
Lisa Rahangdale
1Department of Obstetrics and Gynecology, University of North Carolina-Chapel Hill, Chapel Hill, U.S.A
2Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill, Chapel Hill, U.SA
3Center for AIDS Research, University of North Carolina-Chapel Hill, Chapel Hill, U.SA

DATA AVAILABILITY STATEMENT
Anonymized research data are available upon reasonable request.
Posted June 07, 2024.
Safety and adherence to self-administered intravaginal 5-fluorouracil cream following cervical intraepithelial neoplasia (CIN) 2/3 treatment among HIV-positive women in Kenya: A phase 1 clinical trial
Chemtai Mungo, Jackton Omoto, Cirilus Ogollah, Antony Owaya, Mercy Rop, Gershon Rota, Elizabeth A Bukusi, Jennifer Tang, Lisa Rahangdale
medRxiv 2024.06.06.24308548; doi: https://doi.org/10.1101/2024.06.06.24308548
Safety and adherence to self-administered intravaginal 5-fluorouracil cream following cervical intraepithelial neoplasia (CIN) 2/3 treatment among HIV-positive women in Kenya: A phase 1 clinical trial
Chemtai Mungo, Jackton Omoto, Cirilus Ogollah, Antony Owaya, Mercy Rop, Gershon Rota, Elizabeth A Bukusi, Jennifer Tang, Lisa Rahangdale
medRxiv 2024.06.06.24308548; doi: https://doi.org/10.1101/2024.06.06.24308548
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)